Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
de Weerdt, Iris, Hofland, Tom, de Boer, Renate, Dobber, Johan A., Dubois, Julie, van Nieuwenhuize, Denise, Mobasher, Mehrdad, de Boer, Fransien, Hoogendoorn, Mels, Velders, Gerjo A., van der Klift, Marjolein, Remmerswaal, Ester B.M., Bemelman, Frederike J., Niemann, Carsten U., Kersting, Sabina, Levin, Mark-David, Eldering, Eric, Tonino, Sanne H., Kater, Arnon P.
Published in Blood advances (10.09.2019)
Published in Blood advances (10.09.2019)
Get full text
Journal Article
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial
Kater, Arnon P, Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens H M, van der Kevie-Kersemaekers, Anne-Marie F, Dobber, Johan A, Poulsen, Christian B, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Brieghel, Christian, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T T, Nasserinejad, Kazem, Niemann, Carsten U
Published in The lancet oncology (01.06.2022)
Published in The lancet oncology (01.06.2022)
Get full text
Journal Article
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, Carsten U., Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J., Mous, Rogier, Mellink, Clemens H.M., Dobber, Johan A., Poulsen, Christian B., Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C., Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T.T., Nasserinejad, Kazem, Kater, Arnon P.
Published in Blood (25.02.2021)
Published in Blood (25.02.2021)
Get full text
Journal Article
Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression
Amaador, Karima, Vos, Josephine M. I., Pals, Steven T., Kraan, Willem, Dobber, Johan A., Minnema, Monique C., Koene, Harry R., de Bruin, Peter C., Zwinderman, Aiko H., Kersten, Marie José
Published in Leukemia & lymphoma (16.04.2022)
Published in Leukemia & lymphoma (16.04.2022)
Get full text
Journal Article
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib
Svanberg, Rebecka, Ostrowski, Sisse Rye, Nasserinejad, Kazem, Kersting, Sabina, Dobber, Johan A., Mattson, Mattias, Tran, Hoa T. T., Levin, Mark-David, Mous, Rogier, Kater, Arnon P., Niemann, Carsten U.
Published in Leukemia & lymphoma (05.12.2020)
Published in Leukemia & lymphoma (05.12.2020)
Get full text
Journal Article
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study
Saberi Hosnijeh, Fatemeh, van der Straten, Lina, Kater, Arnon P., van Oers, Marinus H.J., Posthuma, Ward F.M., Chamuleau, Martine E.D., Bellido, Mar, Doorduijn, Jeanette K., van Gelder, Michel, Hoogendoorn, Mels, de Boer, Fransien, te Raa, G. Doreen, Kerst, J. Martijn, Marijt, Erik W.A., Raymakers, Reinier A.P., Koene, Harry R., Schaafsma, Martijn R., Dobber, Johan A., Tonino, Sanne H., Kersting, Sabina S., Langerak, Anton W., Levin, Mark-David
Published in Experimental hematology (01.09.2020)
Published in Experimental hematology (01.09.2020)
Get full text
Journal Article
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
Kersting, Sabina, Dubois, Julie, Nasserinejad, Kazem, Dobber, Johan A, Mellink, Clemens, van der Kevie-Kersemaekers, Anne-Marie F, Evers, Ludo M, de Boer, Fransien, Koene, Harry R, Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A, van der Spek, Ellen, van der Straaten, Hanneke M, Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F M, Visser, Hein P J, Houtenbos, Ilse, Idink, Cecile A M, Issa, Djamila E, Dompeling, Ellen C, van Zaanen, Henk C T, Veelken, Hendrik, Levenga, Henriette, Tick, Lidwine W, Terpstra, Wim E, Tonino, Sanne H, Boyer, Michelle, Mobasher, Mehrdad, Levin, Mark-David, Kater, Arnon P
Published in The Lancet. Haematology (01.03.2022)
Published in The Lancet. Haematology (01.03.2022)
Get more information
Journal Article
Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL
Kater, Arnon P., Kersting, Sabina, van Norden, Yvette, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H., Evers, Ludo M., Croon-de Boer, Fransien, Schreurs, John, van der Spek, Ellen, Visser, Hein, Idink, Cecile, Wittebol, Shulamiet, Hoogendoorn, Mels, Tonino, Sanne H., Mobasher, Mehrdad, Levin, Mark-David
Published in Blood advances (26.12.2018)
Published in Blood advances (26.12.2018)
Get full text
Journal Article
Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial
Levin, Mark-David, Kersting, Sabina, Dubois, Julie M.N., Norden, Yvette, Dobber, Johan A, Jauw, Yvonne W.S., Kevie-Kersemaekers, Anne-Marie van der, Mellink, Clemens, Heer, Koen de, Burg, Leonie van der, Raa, Doreen Te, Boer, Fransien de, Droogendijk, Jolanda, Idink, Cecile, Nijziel, Marten R., Tick, Lidwine W., Ludwig, Inge, Silbermann, Matthijs, Beeker, Aart, Bellido, Mar, Evers, Ludo M., Zwezerijnen, Gerben JC, Niemann, Carsten U, Kater, Arnon P.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Brieghel, Christian, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Nasserinejad, Kazem, Tran, Hoa Thi Tuyet, Levin, Mark-David, Kater, Arnon P.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
van der Straten, Lina, Stege, Claudia A. M., Kersting, Sabina, Nasserinejad, Kazem, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie F., Evers, Ludo M., de Boer, Fransien, Koene, Harry R., Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A., van der Spek, Ellen, van der Straaten, Hanneke M., Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F. M., Visser, Hein P. J., Houtenbos, Ilse, Idink, Cecile A. M., Issa, Djamila E., Dompeling, Ellen C., van Zaanen, Henk C. T., Veelken, J. Hendrik, Levenga, Henriette, Tick, Lidwine W., Terpstra, Wim E., Tonino, Sanne H., Westerweel, Peter E., Langerak, Anton W., Kater, Arnon P., Levin, Mark-David, Beckers, M. M. J., Bekker, A., Bellido, M., de Boer, F., Broers, R., Chamuleau, M., Croockewit, A. J., Dompeling, E. C., Eefting, M., van Gelder, M., Hoogendoorn, M., Houtenbos, I., Doorduijn, J. K., Droogendijk, J., van der Griend, R., de Heer, K., Henkens, C. M. A., Idink, C. A. M., Issa, D. E., van Kampen, R., Kater, A. P., Kersting, S., van der Klift, M., Laterveer, L., Levenga, H., Levin, M-D., Mous, R., Nijland, M., Nijziel, M., van Norden, Y., Posthuma, E. F. M., te Raa, G. D., Raymakers, R. A. P., Regelink, J. C., Sandberg, Y., Schaafsma, M. R., Silbermann, M. H., van der Spek, A. C., van der Straaten, H. M., Tanis, B., Terpstra, W. E., Tick, L. W., Tonino, S. H., Veelken, J. H., Velders, G. A., Vlasveld, L., Visser, H. P. J., Vos, J. M. I., Wittebol, S., van Zaanen, H. C. T.
Published in Blood (28.09.2023)
Published in Blood (28.09.2023)
Get full text
Journal Article
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T, Nasserinejad, Kazem, Levin, Mark-David, Kater, Arnon P.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Kater, Arnon P, van Oers, Marinus H J, van Norden, Yvette, van der Straten, Lina, Driessen, Julia, Posthuma, Ward F M, Schipperus, Martin, Chamuleau, Martine E D, Nijland, Marcel, Doorduijn, Jeanette K, Van Gelder, Michel, Hoogendoorn, Mels, De Croon, Francien, Wittebol, Shulamiet, Kerst, J Martijn, Marijt, Erik W A, Raymakers, Reinier A P, Schaafsma, Martijn R, Dobber, Johan A, Kersting, Sabina, Levin, Mark-David
Published in Haematologica (Roma) (01.01.2019)
Published in Haematologica (Roma) (01.01.2019)
Get full text
Journal Article